Apollo Hospitals Enterprise Ltd Falls 1.24%: 3 Key Factors Driving the Weekly Move

Mar 15 2026 09:02 AM IST
share
Share Via
Apollo Hospitals Enterprise Ltd. closed the week ending 6 March 2026 at Rs.7,722.95, down 1.24% from the previous Friday’s close of Rs.7,820.25. This underperformance contrasted with the broader Sensex, which declined 3.00% over the same period, signalling relative resilience despite sectoral headwinds and mixed technical momentum. The week saw the stock hit an intraday low amid price pressure, followed by a technical shift from bearish to sideways momentum, reflecting a cautious market environment for the hospital sector.

Key Events This Week

2 Mar: Stock opens at Rs.7,792.45, declines 0.36% amid broad market sell-off

4 Mar: Intraday low of Rs.7,480 reached amid price pressure and sector weakness

5 Mar: Technical momentum shifts as stock rebounds 1.43%

6 Mar: Week closes at Rs.7,722.95, down 1.24% for the week but outperforming Sensex

Week Open
Rs.7,820.25
Week Close
Rs.7,722.95
-1.24%
Week Low
Rs.7,480.00
vs Sensex
+1.76%

2 March 2026: Opening Week Amid Market Sell-Off

Apollo Hospitals began the week at Rs.7,792.45, down 0.36% from the previous close. This decline occurred alongside a sharper 1.41% drop in the Sensex, which closed at 35,812.02. The stock’s relative outperformance on this day suggested some defensive qualities amid broad market weakness. Volume was moderate at 14,557 shares, reflecting cautious trading activity as investors digested early-week market volatility.

4 March 2026: Intraday Low and Sector Pressure

The most significant price movement occurred on 4 March, when Apollo Hospitals hit an intraday low of Rs.7,480, a 4.01% drop from the previous close. The stock closed at Rs.7,666.40, down 1.62% on the day, underperforming the hospital sector’s 3.42% decline and the Sensex’s 1.92% fall. This marked the second consecutive day of losses, with a cumulative two-day decline of 4.35%. The intraday low reflected immediate price pressure amid a cautious market environment, with the broader market showing partial recovery after a steep opening drop. Technical indicators at this point showed the stock trading below its 5-day moving average, signalling short-term weakness despite longer-term support from 20-, 50-, 100-, and 200-day averages.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Technical Momentum Shifts Amid Mixed Signals

Throughout the week, Apollo Hospitals’ technical indicators presented a complex picture. On 4 March, the stock’s momentum shifted from sideways to mildly bearish, with the Moving Average Convergence Divergence (MACD) showing bullish weekly signals but mildly bearish monthly trends. The Relative Strength Index (RSI) remained neutral, indicating no extreme overbought or oversold conditions. Bollinger Bands suggested mild bullishness, while daily moving averages turned mildly bearish, reflecting short-term selling pressure. The Know Sure Thing (KST) oscillator and Dow Theory analysis also showed mixed signals, with weekly trends mildly bullish but monthly trends lacking clear direction. On-Balance Volume (OBV) indicators showed no strong volume trend, underscoring the cautious sentiment among traders.

5 March 2026: Rebound and Technical Consolidation

On 5 March, Apollo Hospitals rebounded strongly, closing at Rs.7,775.85, up 1.43% from the previous day’s close. This recovery outpaced the Sensex’s 1.29% gain, signalling renewed buying interest amid a volatile market. The stock traded between Rs.7,634.20 and Rs.7,796.45 intraday, remaining below its 52-week high of Rs.8,099.00 but showing resilience above recent lows. Technical momentum began shifting from bearish to sideways, suggesting a consolidation phase. Weekly MACD remained bullish, while monthly MACD stayed mildly bearish, reflecting ongoing uncertainty in longer-term trends. The RSI and Bollinger Bands continued to indicate a neutral to mildly bullish stance, supporting the view of a balanced market environment.

Is Apollo Hospitals Enterprise Ltd. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

6 March 2026: Week Closes with Sideways Momentum

The week concluded on 6 March with Apollo Hospitals closing at Rs.7,722.95, down 0.68% from the previous day but still outperforming the Sensex, which fell 0.98%. The stock’s price action reflected a shift from mild bearishness to a sideways trend, indicating a period of consolidation. Technical indicators remained mixed: weekly MACD bullish, monthly MACD mildly bearish; RSI neutral; Bollinger Bands mildly bullish. The Know Sure Thing (KST) oscillator and Dow Theory analysis echoed this nuanced stance, with short-term optimism tempered by longer-term caution. On-Balance Volume (OBV) was mildly bullish weekly but neutral monthly, suggesting volume flows supported recent gains without strong conviction. The Mojo Score stood at 61.0 with a Hold rating, reflecting a cautious but stable outlook amid evolving market conditions.

Date Stock Price Day Change Sensex Day Change
2026-03-02 Rs.7,792.45 -0.36% 35,812.02 -1.41%
2026-03-04 Rs.7,666.40 -1.62% 35,125.64 -1.92%
2026-03-05 Rs.7,775.85 +1.43% 35,579.03 +1.29%
2026-03-06 Rs.7,722.95 -0.68% 35,232.05 -0.98%

Key Takeaways

Relative Resilience: Despite a 1.24% weekly decline, Apollo Hospitals outperformed the Sensex’s 3.00% fall, highlighting defensive qualities amid market volatility.

Intraday Volatility: The stock’s intraday low of Rs.7,480 on 4 March reflected short-term selling pressure linked to sector weakness and cautious investor sentiment.

Mixed Technical Signals: Divergent MACD readings, neutral RSI, and mildly bullish Bollinger Bands indicate a complex technical environment with short-term optimism offset by longer-term caution.

Consolidation Phase: The shift from bearish to sideways momentum suggests the stock is in a consolidation phase, awaiting clearer directional cues.

Mojo Grade Downgrade: The Hold rating and Mojo Score of 61.0 reflect a more cautious stance following a downgrade from Buy, aligning with the observed technical and market dynamics.

Conclusion

Apollo Hospitals Enterprise Ltd. navigated a challenging week marked by sectoral headwinds and mixed technical momentum. While the stock experienced an intraday low and short-term price pressure, it demonstrated relative strength by outperforming the broader Sensex decline. The technical landscape remains nuanced, with indicators signalling a consolidation phase rather than a decisive trend. The downgrade to a Hold rating underscores the need for cautious monitoring as the stock balances between short-term rallies and longer-term uncertainties. Investors should watch for confirmation of breakout or breakdown signals in the coming weeks to gauge the stock’s next directional move within the hospital sector’s evolving market context.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News